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SUMMARY
The first epithelial to mesenchymal transition (EMT) occurs in trophoblast stem (TS) cells during 
implantation. Inactivation of the serine/threonine kinase MAP3K4 in TS cells (TSKI4 cells) 
induces an intermediate state of EMT, where cells retain stemness, lose epithelial markers, and 
gain mesenchymal characteristics. Investigation of relationships between MAP3K4 activity, 
stemness, and EMT in TS cells may reveal key regulators of EMT. Here, we show that MAP3K4 
activity controls EMT through the ubiquitination and degradation of HDAC6. Loss of MAP3K4 
activity in TSKI4 cells results in elevated HDAC6 expression and the deacetylation of cytoplasmic 
and nuclear targets. In the nucleus, HDAC6 deacetylates the promoters of tight junction genes, 
promoting the dissolution of tight junctions. Importantly, HDAC6 knockdown in TSKI4 cells 
restores epithelial features including cell-cell adhesion and barrier formation. These data define an 
epigenetic role for HDAC6 in regulating gene expression during transitions between epithelial and 
mesenchymal phenotypes.
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Mobley et al. find that HDAC6 is regulated by MAP3K4 during trophoblast stem cell 
differentiation and EMT. MAP3K4 promotes HDAC6 ubiquitination and degradation, maintaining 
the epithelial state. During EMT, HDAC6 directly deacetylates histones on epithelial gene 
promoters such as claudin6 and occludin, promoting the dissolution of tight junctions.
INTRODUCTION
Epithelial to mesenchymal transition (EMT) is a morphogenetic program controlling cellular 
phenotype that is essential for the development and maintenance of multicellular organisms 
(Thiery et al., 2009). During EMT, epithelial cells lose apical-basal polarity and cell-cell 
adhesion while acquiring a front-back, mesenchymal morphology. This transition converts 
nonmotile epithelial cells to invasive mesenchymal cells. In EMT, cells lose the expression 
of epithelial markers such as the cell-cell adhesion protein E-cadherin, and gain the 
expression of mesenchymal markers like N-cadherin and vimentin. In addition, several 
transcription factors promote EMT, including Lef1, Snai1, and Twist (Lamouille et al., 
2014). EMT is responsible for the creation of many cell types during embryogenesis. 
Further, EMT is activated during tissue regeneration after injury and in disease states such as 
organ fibrosis and cancer metastasis.
One of the first developmental EMT events occurs during implantation (Thiery et al., 2009). 
A subset of epithelial, trophoblast stem (TS) cells in the trophectoderm convert to invasive 
trophoblast giant cells that invade the mother and establish placentation. TS cells can be 
isolated from pre-implantation blastocysts and cultured indefinitely. The stemness properties 
(self-renewal and potency) of TS cells are maintained by the presence of FGF4 and 
conditioned media from mitotically inactivated mouse embryonic fibroblasts (MEF-CM) 
(Tanaka et al., 1998). Removal of FGF4 and MEF-CM induces TS cell EMT. Cells lose the 
expression of E-cadherin, and convert into invasive trophoblast giant cells with 
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mesenchymal properties, including expression of N-cadherin, vimentin, fibronectin, Snai1 
and Lef1 (Abell et al., 2011). Recently, we reported the isolation of TS cells from 
conceptuses of mice with a targeted mutation of MAP3K4 that inactivates its kinase activity 
(Abell et al., 2009; Abell et al., 2011). Mice expressing kinase-inactive MAP3K4 (KI4 mice) 
display developmental phenotypes due to perturbed EMT including neural tube, skeletal, and 
implantation defects (Abell et al., 2009; Abell et al., 2005). TS cells isolated from KI4 
conceptuses (TSKI4) exhibit characteristics of EMT while maintaining their stemness 
properties (Abell et al., 2011). Specifically, undifferentiated TSKI4 cells have a more 
mesenchymal morphology with reduced E-cadherin, and increased N-cadherin and vimentin 
relative to wild-type (TSWT) cells. Also, EMT-inducing transcription factors Snai1 and Twist 
are elevated in TSKI4 cells and cells display increased invasiveness compared to TSWT cells.
MAP3K4 activates CBP, a histone acetyltransferase (HAT), to promote the acetylation of 
histones H2A and H2B (H2A/H2BAc) on the promoters of genes critical for maintaining the 
epithelial phenotype (Abell et al., 2011). Loss of MAP3K4 activity results in reduced CBP-
mediated acetylation and the conversion of epithelial stem cells to a more mesenchymal 
morphology. Because CBP acetylates numerous targets in addition to histones, we predicted 
that MAP3K4 regulates the acetylation of additional proteins. Herein, we show MAP3K4 
activity represses HDAC6 expression and activity required for deacetylation of cytoplasmic 
and nuclear proteins important for EMT. Loss of MAP3K4 activity in TSKI4 cells increases 
HDAC6 expression and activity, and knockdown of HDAC6 in TSKI4 cells restores epithelial 
features. We define a key nuclear role for HDAC6 in the deacetylation of promoters of genes 
encoding tight junction proteins, resulting in diminished cell-cell adhesion characteristic of 
the mesenchymal phenotype. In addition, we identify MAP3K4/HDAC6 regulated genes 
with previously undescribed roles in EMT. Our findings demonstrate MAP3K4 coordinates 
HDAC and HAT activities for the transition of stem cells between epithelial and 
mesenchymal states.
RESULTS
Reduced Acetylation of Proteins in TSKI4 Cells Is Due to Increased Expression and Activity 
of HDAC6
MAP3K4 activates CBP-mediated H2A/H2BAc to promote the expression of genes essential 
for maintaining the epithelial phenotype (Abell et al., 2011). Inactivation of MAP3K4 kinase 
activity in TSKI4 cells results in the loss of H2A/H2BAc and the gain of mesenchymal 
features. To identify MAP3K4 dependent changes in protein acetylation, we treated TSWT 
and TSKI4 cells with the deacetylase inhibitor, Trichostatin A (TSA), and compared lysine 
acetylation by Western blotting. Acetylation of several proteins was reduced in TSKI4 cells 
compared to TSWT cells, including the acetylation of a 50 kDa protein identified as 
acetylated α-tubulin (Ac-tubulin)(Figure 1A). Ac-tubulin was decreased in untreated TSKI4 
cells relative to TSWT cells, indicating a significant deregulation of tubulin acetylation with 
loss of MAP3K4 kinase activity (Figure 1B).
α-tubulin can be deacetylated by both HDAC6 and SIRT2 (Hubbert et al., 2002; North et al., 
2003). Real time quantitative PCR (qRT-PCR) showed that HDAC6 transcripts were 
increased four-fold in TSKI4 cells relative to TSWT cells, whereas SIRT2 transcripts were 
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only modestly changed (Figures 1C and S1A). HDAC6 protein expression was also 
increased 5.8-fold in TSKI4 cells, whereas SIRT2 protein was not significantly changed 
(Figures 1D and S1B). To determine if decreased Ac-tubulin in TSKI4 cells was due to 
increased expression of HDAC6, we reduced HDAC6 expression in TSKI4 cells using two 
different HDAC6 lentiviral shRNAs. HDAC6 message and protein levels were partially 
reduced in TSKI4 cells with HDAC6 sh1, but HDAC6 levels remained above TSWT levels 
(Figures 1C and 1D). HDAC6 knockdown in TSKI4 cells with HDAC6 sh2 reduced HDAC6 
message and protein levels below that of TSWT cells (Figures 1C and 1D). Knockdown of 
HDAC6 in TSKI4 cells restored Ac-tubulin to either near wild-type levels with sh1 or above 
wild-type levels with sh2 (Figure 1D). Examination of total cytoplasmic deacetylase activity 
revealed a 50% increase in TSKI4 cells relative to TSWT cells that was reduced by 
knockdown of HDAC6 in TSKI4 cells (Figure 1E). Further, HDAC6 activity was increased 
2.6-fold in HDAC6 immunoprecipitates from TSKI4 cells relative to TSWT cells (Figure 1F). 
Together, these findings show MAP3K4 regulates the expression and activity of HDAC6.
Increased HDAC6 Expression and Activity Induce Specific Features of EMT in TSKI4 Cells
TSWT cells have an epithelial morphology, as compared to TSKI4 cells that have an 
intermediate phenotype with both epithelial and mesenchymal characteristics (Figures 2A 
and 2B). HDAC6 knockdown in TSKI4 cells reduced mesenchymal features and partially 
restored an epithelial morphology, suggesting that increased HDAC6 expression and activity 
in TSKI4 cells promote EMT (Figures 2C and 2D). Importantly, TSWT cells retained an 
epithelial morphology after HDAC6 knockdown in TSWT cells (Figure S2A–C).
As a measure of the epithelial state, we examined the expression and localization of E-
cadherin, a key marker of epithelial cells. E-cadherin levels were similar between TSWT 
cells and TSKI4 cells and were not altered by HDAC6 knockdown (Figures 2E and 2F). 
However, E-cadherin localization was altered. Unlike TSWT cells with E-cadherin 
immunostaining at the plasma membrane, E-cadherin was mislocalized to cytoplasmic 
puncta in TSKI4 cells (Figure 2G). Knockdown of HDAC6 in TSKI4 cells partially restored 
E-cadherin localization to the plasma membrane (Figure 2G). Expression of epithelial 
keratins (Krt8 and Krt18) was reduced in TSKI4 cells and restored by HDAC6 knockdown, 
further showing that HDAC6 represses epithelial characteristics (Figure 2H). Krt8, Krt18 
and Cdh1 levels were increased by knockdown of HDAC6 in TSWT cells (Figure S2D).
To further address the role of HDAC6 in TSKI4 cell EMT, we measured the expression of 
EMT inducing transcription factors and invasiveness. Snai1, Ets2 and Twist1 transcripts 
were elevated in TSKI4 cells, and HDAC6 knockdown partially reduced Snai1 and Ets2 
expression, suggesting a modest role for HDAC6 in transcriptional regulation of EMT-
inducing transcription factors (Figures 2I and 2J). TSKI4 cells were twenty times more 
invasive than TSWT cells and knockdown of HDAC6 in TSKI4 cells decreased invasiveness 
(Figure 2K). These data indicated that MAP3K4 regulates specific aspects of TS cell EMT 
through HDAC6.
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HDAC6 Expression and Activity Are Induced by TS Cell Differentiation and EMT
Removal of FGF4, heparin, and MEF-CM induces TS cell differentiation and EMT (Abell et 
al., 2011). We hypothesized that HDAC6 expression and/or activity were regulated during 
differentiation. As shown in Figure 3A and 3B, HDAC6 transcript and protein were induced 
by TSWT cell differentiation for four days. This induction of HDAC6 expression was 
associated with increased cytoplasmic HDAC activity showing that normal stem cell 
differentiation and EMT were associated with increased HDAC6 expression and activity 
(Figure 3C). Coexpression of wild-type MAP3K4 with HDAC6 in 293 cells inhibited 
HDAC6 activity (Figure 3D). Conversely, HDAC6 activity was higher in the presence of 
kinase-inactive MAP3K4 as compared to wild-type MAP3K4, suggesting that kinase-
inactive MAP3K4 (KI) failed to inhibit HDAC6 activity (Figure 3E).
Interaction of MAP3K4 and HDAC6
Based on our findings that wild-type MAP3K4 inhibited HDAC6 activity, we determined if 
MAP3K4 and HDAC6 were bound in a protein complex. HA-tagged MAP3K4 was 
coexpressed with either Flag-tagged HDAC6 or HDAC7 and Flag-tagged proteins were 
immunoprecipitated with anti-Flag antibody. HA-MAP3K4 coimmunoprecipitated with 
Flag-HDAC6, but not Flag-HDAC7, demonstrating the specific binding of MAP3K4 to 
HDAC6 (Figure 3F). To define the domain of MAP3K4 interacting with HDAC6, we deleted 
the N-terminus of MAP3K4 leaving only the kinase domain (HA-MAP3K4 KD). The kinase 
domain alone bound HDAC6 similarly to full-length MAP3K4 demonstrating that the kinase 
domain of MAP3K4 was sufficient for HDAC6 binding (Figure 3G). TSKI4 cells have a 
targeted mutation of the catalytic lysine 1361 to arginine in the kinase domain of MAP3K4. 
Because binding of HDAC6 to MAP3K4 occurs through the kinase domain of MAP3K4, we 
determined if this mutation altered HDAC6 binding. As shown in Figure 3H, kinase-inactive 
HA-MAP3K4KI bound HDAC6 at levels similar to wild-type HA-MAP3K4, showing this 
kinase domain mutation does not impair binding. This interaction was confirmed by 
coimmunoprecipitation of endogenous MAP3K4 and HDAC6 in both murine TS cells and 
human 293 cells (Figures 3I and 3J). Endogenous KI MAP3K4 coimmunoprecipitated with 
HDAC6 in TSKI4 cells, further demonstrating that kinase-inactive MAP3K4 bound HDAC6 
(Figure 3I).
MAP3K4 Promotes the Ubiquitination and Degradation of HDAC6
Although MAP3K4KI retained HDAC6 binding, it failed to inhibit HDAC6 activity. Further, 
the lack of MAP3K4 kinase activity resulted in increased HDAC6 protein levels. Elevated 
HDAC6 in TSKI4 cells could result from cells being in an intermediate state of EMT, and/or 
a direct effect of MAP3K4 on HDAC6 protein stability. It has previously been shown that 
HDAC6 is itself an E3 ligase capable of autoubiquitination (Zhang et al., 2014). In addition, 
HDAC6 is ubiquitinated by CHIP, an E3 ligase, and subsequently degraded (Cook et al., 
2012). To determine the effect of MAP3K4 on HDAC6 ubiquitination, HA-MAP3K4 and 
Flag-HDAC6 were coexpressed with Myc-tagged ubiquitin. When expressed alone, both 
Flag-HDAC6 and HA-MAP3K4 were ubiquitinated (Figure 4A). Coexpression of HA-
MAP3K4 with Flag-HDAC6 dramatically increased the ubiquitination of Flag-HDAC6 
(Figure 4A, upper panel). In contrast, Flag-HDAC6 did not significantly alter the 
Mobley et al. Page 5
Cell Rep. Author manuscript; available in PMC 2017 July 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
ubiquitination of HA-MAP3K4 (Figure 4A, lower panel). Based on the increased 
endogenous HDAC6 protein levels in TSKI4 cells, we predicted that kinase-inactive 
MAP3K4 might be deficient in promoting HDAC6 ubiquitination. When coexpressed, HA-
MAP3K4KI failed to promote the ubiquitination of Flag-HDAC6 (Figure 4B). Further, the 
ubiquitination of HA-MAP3K4KI was decreased compared to HA-MAP3K4WT (Figure 4C). 
These changes were not HDAC6 dependent, suggesting the kinase activity of MAP3K4 
regulates its ubiquitination independent of HDAC6 (Figure 4C). To examine the impact of 
MAP3K4 on endogenous HDAC6, TSWT cells and TSKI4 cells were treated with 
cycloheximide (CHX) to inhibit protein synthesis. At four and eight hours of CHX 
treatment, HDAC6 levels were significantly decreased in TSWT cells, whereas HDAC6 
levels in TSKI4 cells remained elevated (Figure 4D). Together, these data suggested that 
MAP3K4 kinase activity decreases the stability of HDAC6 protein. Loss of HDAC6 
degradation in TSKI4 cells resulted in elevated levels of HDAC6 protein.
Loss of MAP3K4 Kinase Activity Increases HDAC6 Nuclear Localization and Function
Cytoplasmic functions of HDAC6 are well studied, while the roles of HDAC6 in the nucleus 
are not well defined (Valenzuela-Fernandez et al., 2008). TSKI4 cells have increased nuclear 
localization of HDAC6 as compared to TSWT cells (Figures 5A and 5B and see Figure S3A). 
Increased HDAC6 expression correlated with increased nuclear HDAC activity in TSKI4 
cells that was reduced by HDAC6 knockdown (Figure 5C). TSKI4 cells display a selective 
loss of H2A/H2BAc, whereas histones H3 and H4 are not altered (Abell et al., 2011). To 
determine if increased HDAC6 contributed to loss of H2A/H2BAc, we examined histone 
acetylation after HDAC6 knockdown in TSKI4 cells. H2AK5 and H2BK5 acetylation was 
restored by HDAC6 knockdown in TSKI4 cells, demonstrating HDAC6 regulation of specific 
histone acetylation (Figure 5D). Similar to TSKI4 cell EMT, normal differentiation for four 
days also increased nuclear localization and activity of HDAC6 in TSWT cells (Figure 5E 
and 5F). Differentiation of TS cells reduced acetylation of histones H2A, H2B, H3 and H4 
(Figure 5G). As HDAC6 expression and activity increase in the nucleus with differentiation, 
we determined if HDAC6 was involved in the deacetylation of histones during normal TS 
cell differentiation. As shown in Figure 5H, HDAC6 knockdown in TSKI4 cells resulted in 
the selective maintenance of H2A/H2BAc during differentiation, whereas deacetylation of 
H3 and H4 was not affected, suggesting that HDAC6 selectively deacetylated histones H2A 
and H2B (Figure 5H). Together, these data demonstrate a key role for HDAC6 during 
differentiation and EMT by promoting the selective deacetylation of H2A/H2B.
HDAC6 Inhibits the Expression of Tight Junction Proteins by Direct Promoter Binding and 
Deacetylation of H2BK5
Based on the presence of HDAC6 in the nucleus of TSKI4 cells and HDAC6 dependent 
changes in H2BK5Ac, we hypothesized that HDAC6 directly deacetylates H2BK5 on 
specific gene promoters in TSKI4 cells. To identify MAP3K4/HDAC6/H2BK5Ac-dependent 
genes in TSKI4 cells, we performed anti-H2BK5Ac chromatin immunoprecipitation coupled 
to deep sequencing (ChIP-seq) of TSWT, TSKI4 and TSKI4 HDAC6sh2 cells. Analysis of 
H2BK5Ac-ChIP-seq data identified 1817 genes with decreased H2BK5Ac in TSKI4 cells 
relative to TSWT cells that increased in TSKI4 HDAC6sh2 cells (Figures 6A and 6B). RNA-
seq showed decreased transcripts of 2624 genes in TSKI4 cells relative to TSWT cells, whose 
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expression increased in TSKI4 HDAC6sh2 cells, suggesting their HDAC6 dependence 
(Figure 6C). Comparison of genes with MAP3K4/HDAC6 dependent H2BK5Ac and genes 
with MAP3K4/HDAC6 dependent expression identified 514 MAP3K4/HDAC6/H2BK5Ac 
dependent genes (Figures 6C and 6D and Table S1). These genes showed HDAC6 dependent 
gene expression and promoter H2BK5Ac, implicating regulation by HDAC6 (Table S1). 
ToppFunn gene ontology (GO) analyses of Biological Processes of these 514 genes showed 
significant enrichment in several processes including the organization of cell-cell junctions 
and the actin cytoskeleton, tight junction assembly, and epithelium development (Figure 
S4A). Further, ToppFunn GO analyses of Cellular Components revealed enrichment in genes 
important to cell-cell, apical, and tight junctions (Figure 6E). Fold changes relative to TSWT 
cells in genes from the Cell-Cell Junction category showed decreased expression in TSKI4 
cells that was restored by HDAC6 knockdown (Figure S4B). With the exception of the 
membrane raft category, all enriched Cellular Component categories included the gene 
Cldn6, a key tight junction protein mediating cell-cell adhesion in epithelial stem cells 
(Figure 6E). Read density plots showed reduced H2BK5Ac near the transcription start site 
(TSS) of several tight junction genes including Clnd6 and Tjp1 in TSKI4 cells relative to 
TSWT cells that was restored by HDAC6 knockdown (Figures 6F and S5A–D). Significantly, 
H2BK5Ac at the TSS of the stemness marker Cdx2 was not dependent on MAP3K4 or 
HDAC6 (Figure S5E). Reduced Cldn6 promoter H2BK5Ac correlated with decreased Cldn6 
transcript and protein in TSKI4 cells (Figures 6G and 6H). Further, knockdown of HDAC6 to 
levels below wild-type (sh2) restored Cldn6 expression (Figures 6G and 6H). 
Immunofluorescence confocal microscopy revealed the co-localization of Cldn6 and ZO-1 at 
cell-cell junctions in TSWT cells (Figure 6I). In contrast, Cldn6 was undetectable in TSKI4 
cells and ZO-1 (Tjp1) was mislocalized (Figures 6I). Expression and localization of Cldn6 
and ZO-1 were partially restored in TSKI4 HDAC6sh2 cells, suggesting a key role for 
HDAC6 in the dissolution of tight junctions (Figure 6I). Three dimensional confocal 
microscopy images showed loss of tight junctions in TSKI4 cells that are restored by HDAC6 
knockdown (Figures S5F and S5G). Using fluorescent dye exclusion assays to measure 
barrier function, we observed increased dye flux through confluent monolayers of TSKI4 
cells relative to TSWT cells, suggesting that loss of MAP3K4 compromises barrier function 
(Figure 6J). Knockdown of HDAC6 in TSKI4 cells inhibited dye flux to levels below TSWT 
cells, suggesting that HDAC6 impairs barrier function (Figure 6J).
The findings thus far implicated HDAC6 in the transcriptional regulation of Cldn6 and other 
tight junction proteins. To determine if HDAC6 represses Cldn6 expression through direct 
binding and deacetylation of the Cldn6 promoter, we compared H2BK5Ac and HDAC6 
ChIP coupled to qRT-PCR (ChIP-PCR). Consistent with H2BK5Ac ChIP-seq, H2BK5Ac 
was decreased on the Cldn6 promoter in TSKI4 cells by H2BK5Ac ChIP-PCR (Figure 6K). 
Knockdown of HDAC6 in TSKI4 cells restored H2BK5Ac on the Cldn6 promoter, 
suggesting that HDAC6 might be positioned on the Cldn6 promoter in TSKI4 cells (Figure 
6K). As measured by anti-HDAC6 ChIP-PCR, HDAC6 was enriched on the Cldn6 promoter 
in TSKI4 cells compared to TSWT cells (Figure 6L). Similar results were observed for the 
tight junction protein Ocln whose transcript levels were restored in TSKI4 HDAC6sh2 cells 
compared to TSKI4 cells (Figure S5H). ChIP-PCR showed reduced Ocln promoter 
H2BK5Ac and increased HDAC6 enrichment in TSKI4 cells (Figures S5I and S5J). 
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Together, these data demonstrate MAP3K4 dependent regulation of tight junction gene 
expression by direct HDAC6 binding and H2BK5Ac promoter deacetylation.
Identification of HDAC6 Regulated Genes with Previously Undefined Roles in Maintaining 
the Epithelial Phenotype
We previously identified 31 genes downregulated in both TSKI4 and claudin-low breast 
cancer (CL) cells, also having reduced H2BK5 promoter acetylation in TSKI4 cells (Abell et 
al., 2011). Of these 31 genes, eight were also present in the 514 MAP3K4/HDAC6/
H2BK5Ac gene list (Table S1). We predicted that a subset of these genes is directly 
downregulated by HDAC6 deacetylation of H2BK5 in TSKI4 cells, conferring a 
mesenchymal phenotype. To identify genes most likely to be directly downregulated by 
HDAC6 during EMT, we sorted the eight CL/MAP3K4/HDAC6/H2BK5Ac genes based on 
the restoration of promoter H2BK5Ac after HDAC6 knockdown. Ahnak, Pik3r3 and Suox 
showed the greatest restoration of H2BK5Ac after HDAC6 knockdown (Figure S6A–C). 
Unlike Cldn6 and Ocln, these genes have not been previously associated with EMT. Using 
qRT-PCR, we validated the reduced expression of Ahnak, Pik3r3, and Suox in TSKI4 cells 
that was restored by knockdown of HDAC6 (Figures 7A–C). Treatment of TSKI4 cells with 
tubastatin, an HDAC6 selective inhibitor, partially restored the expression of Ahnak, Pik3r3, 
and Suox (Figures 7D–F). Interestingly, tubastatin treatment also reduced HDAC6 transcript 
levels, suggesting that HDAC6 can regulate its own expression (Figure S6D). Individual 
shRNA knockdown of Ahnak, Pik3r3, and Suox in TSWT cells produced morphological 
changes characterized by a loss of epithelial morphology and a gain of mesenchymal 
morphology (Figure 7G–K). In addition, knockdown selectively altered the transcript levels 
of epithelial and mesenchymal markers, suggesting a role of these genes in maintaining the 
epithelial phenotype (Figures 7L and 7M).
HDAC6 Is Bound to the Promoters of Previously Unidentified Genes Important for 
Maintaining the Epithelial Phenotype
Consistent with H2BK5Ac ChIP-seq, H2BK5Ac ChIP-PCR demonstrated the loss of 
H2BK5Ac on the promoters of Ahnak, Pik3r3, and Suox in TSKI4 cells that increased in 
TSKI4 HDAC6sh2 cells (Figure 7N). HDAC6 ChIP-PCR revealed binding of HDAC6 to the 
promoters of Ahnak, Pik3r3, and Suox, demonstrating direct regulation by HDAC6 (Figure 
7O). In TSKI4 cells, HDAC6 was enriched at these promoters, consistent with the reduction 
of H2BK5Ac on these genes. These findings suggest that HDAC6 directly represses the 
expression of Ahnak, Pik3r3, and Suox by deacetylation of H2BK5, contributing to EMT in 
TSKI4 cells.
DISCUSSION
Herein, we establish MAP3K4 as a key coordinator of chromatin modifiers during 
transitions between epithelial and mesenchymal states. Our previous work showed MAP3K4 
activates CBP to promote H2A/H2BAc on epithelial genes (Abell et al., 2011). Here, our 
findings show MAP3K4 promotes the ubiquitination and degradation of HDAC6. Loss of 
MAP3K4 activity in TSKI4 cells results in increased cytoplasmic and nuclear expression and 
activity of HDAC6. In addition to showing that MAP3K4 regulates HDAC6 deacetylation of 
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α-tubulin, we demonstrate that HDAC6 promotes differentiation and EMT in TS cells by 
deacetylating H2A/H2BAc on genes maintaining the epithelial phenotype. Specifically, 
HDAC6 is bound to promoters of several tight junction genes including Cldn6, repressing 
expression by directly deacetylating H2BK5. Importantly, we have used this innovative 
MAP3K4/HDAC6 regulated system to identify genes like Ahnak, Pik3r3, and Suox that 
regulate EMT. Pik3r3 encoding a PI3K regulatory subunit and Suox encoding a 
mitochondrial sulfite oxidase lack previously defined roles in EMT. Ahnak is a large 
scaffolding protein that colocalizes with ZO-1 in endothelial cell tight junctions, consistent 
with a role for Ahnak in EMT (Gentil et al., 2005). Together, these findings demonstrate that 
MAP3K4 maintains the epithelial state by preventing histone deacetylation by HDAC6, 
further implicating MAP3K4 as a key coordinator of cellular phenotype.
We have identified an interaction between HDAC6 and MAP3K4 mediated through the 
kinase domain of MAP3K4 in epithelial stem cells. There is only one other demonstration of 
MAP3K/HDAC complex formation. HDAC4 binds and deacetylates MAP3K2, promoting 
activation of MAP3K2 essential for the regulation of muscle atrophy (Choi et al., 2012). We 
predict that MAP3K/HDAC protein complex formation may represent conserved 
mechanisms controlling cellular function.
HDAC6 transcript and protein are increased in both TSKI4 cells and differentiating TS cells 
in EMT. TSKI4 cells are in an intermediate state of EMT, suggesting an explanation for 
elevated HDAC6 transcript and protein (Abell et al., 2011). Alternatively, MAP3K4 may 
repress HDAC6 transcripts through the regulation of MAPK-dependent transcription factors 
or AP1 controlled microRNAs (Bae et al., 2015). In addition, HDAC6 inhibition with 
tubastatin decreased HDAC6 transcript levels, suggesting that HDAC6 may regulate its own 
expression. Importantly, we show MAP3K4 promotes the ubiquitination and degradation of 
HDAC6 that is lost in TSKI4 cells, identifying a mechanism regulating HDAC6 protein 
expression.
The HDAC family of proteins has been implicated in EMT, primarily through the study of 
broad-spectrum HDAC inhibitors that inhibit and/or reverse fibrosis of the heart, lens, liver, 
lung, and kidney (Pang and Zhuang, 2010). For example, pan-HDAC inhibition suppresses 
TGFβ-induced EMT in the kidney, but the precise mechanisms are unknown. Two studies 
have implicated cytoplasmic HDAC6 in the regulation of EMT (Mak et al., 2012; Shan et 
al., 2008). Mak et al found that HDAC6 promotes the mesenchymal state in ovarian and 
colon cancer by preventing CD133 trafficking to and degradation by the endosome-
lysosome. Importantly, HDAC6 knockdown in these cancer cells restored E-cadherin 
expression. In A549 lung adenocarcinoma cells, TGFβ-induced EMT increased HDAC6 
deacetylation of α-tubulin, but not HDAC6 expression (Shan et al., 2008). In contrast, we 
show MAP3K4-dependent changes in the expression and activity of HDAC6. While 
previous studies defined cytoplasmic functions, we show a direct nuclear role of HDAC6 in 
TS cells, where HDAC6 is physically bound to and deacetylating promoters of tight junction 
genes, promoting EMT. Similar to CBP, HDAC6 selectively regulates H2A/H2BAc. Loss of 
H2A/H2BAc is associated with the initiation of EMT and the metastable state (Abell et al., 
2011). In contrast, H3 and H4 acetylation is p300 dependent in epithelial TS cells, but the 
deacetylases for H3 and H4 in TS cells are undefined (Abell et al., 2011). Loss of 
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acetylation of all four histones results in differentiation induced EMT (Abell et al., 2011). 
We predict that distinct acetyltransferases and deacetylases may control EMT initiation 
versus terminal differentiation EMT in TS cells.
KI4 mice lacking MAP3K4 activity and CBP deficient mice share several overlapping 
developmental phenotypes associated with EMT including neural tube, craniofacial and 
skeletal defects (Abell et al., 2005; Tanaka et al., 1997). In addition, KI4 mice display 
placental defects (Abell et al., 2009). In contrast, HDAC6 knockout mice develop normally 
(Zhang et al., 2008). Lack of placental phenotypes in CBP and HDAC6 knockouts may be 
due to compensation by other HATs and HDACs. Alternatively, the KI4 placental phenotype 
may reflect both loss of acetylation by CBP and gain of deacetylation by HDAC6, 
promoting EMT and trophoblast hyperinvasion.
We demonstrate an epigenetic role for HDAC6 in the nucleus of TS cells. Although HDAC6 
has been found in the nucleus of MCF7 breast cancer cells and T cells, HDAC6 is located 
primarily in the cytoplasm of most cells (Riolo et al., 2012; Wang et al., 2009). 
Overexpression studies show that HDAC6 is retained in the cytoplasm by p300-mediated 
acetylation, which prevents interaction with importin-α (Liu et al., 2012). However, p300 
activity is not altered in TSKI4 cells (Abell et al., 2011). As p300 and CBP have overlapping 
functions in some cell types, HDAC6 may be retained in the cytoplasm in TSWT cells by 
CBP dependent acetylation. In TSKI4 cells, HDAC6 may be hypoacetylated either due to 
lack of CBP activity, or an overall increase in cytoplasmic HDAC activity.
Our work defines a direct role of HDAC6 in regulating the dissolution of tight junctions, a 
key step in EMT. Claudins are key components of tight junctions in epithelial cells, 
promoting cell-cell adhesion and barrier function (Kwon, 2013). Claudins are lost in the 
highly invasive and metastatic claudin-low breast cancer subtype (Prat and Perou, 2011). 
Further, re-expression of Cldn6 in MCF7 breast cancer cells reduces invasiveness and 
restores drug sensitivity (Kwon, 2013). Cldn6 is expressed at higher levels in stem cells as 
compared to somatic cells, but transcriptional regulators of claudins are poorly defined 
(Furuse and Moriwaki, 2009; Kwon, 2013). In addition to Cldn6, MAP3K4 and HDAC6 
control the expression of several other tight junction proteins including Cldn1, Cldn9, Ocln, 
Tjp1, Tjp2 and Tjp3, suggesting a key role for HDAC6 in disrupting tight junctions. We also 
demonstrate HDAC6 dependent changes in localization of the adherens junction protein E-
cadherin, indicating additional non-transcriptional mechanisms controlled by HDAC6 that 
regulate EMT. These data suggest that MAP3K4 inhibition of HDAC6 is essential for 
maintaining cell-cell adhesion in TS cells.
In summary, we have defined a mechanism by which MAP3K4 directs epigenetic modifiers 
to control TS cell phenotype. Our data clearly demonstrate that MAP3K4 inhibits the 
activity of HDAC6, controlling H2A/H2BAc on genes important for the epithelial state. A 
key question remaining is whether CBP and HDAC6 coregulate the same genes. Further, 
how is the specificity and selectivity of CBP and HDAC6 binding to gene promoters 
mediated? Future studies will examine the coregulation of genes by MAP3K4, CBP and 
HDAC6, defining an epigenetic mechanism for controlling normal stem cell EMT during 
development. As MAP3K4, CBP and HDAC6 are therapeutically tractable targets, this work 
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may provide insight into the study of pathological EMT states in which epithelial cells may 
adopt a metastable EMT phenotype.
EXPERIMENTAL PROCEDURES
Cell Lines, Culture Conditions, and Transfections
TSWT and TSKI4 cells were isolated as previously described from crosses of mice 
heterozygous for a targeted mutation of MAP3K4 (K1361R) (Abell et al., 2011). TS cells 
were cultured without feeders in 30% TS media (RPMI 1640, 20% fetal bovine serum, 1% 
penicillin and streptomycin, 1% L-glutamine, 1% sodium pyruvate, and 100 μM β-
mercaptoethanol) and 70% MEF-CM. For maintenance of stemness, TS medium was 
supplemented with FGF4 (37.5 ng/ml) and Heparin (1 mg/ml). Invasion assays, 
differentiation, 293 culture, transfection, and plasmids are specified in Supplemental 
Experimental Procedures.
Lentivirus Production, Infections, and shRNA Knockdown of HDAC6
Replication incompetent lentivirus was produced as previously described (Abell et al., 
2011). Briefly, 293 cells were transfected with control or shRNA constructs in pLKO.1 
(Open Biosystems, TRCN0000008414 and TRCN0000008415), pMD2.G and psPAX2 
(Addgene) using Lipofectamine plus (Invitrogen). Infections were performed as previously 
described (Abell et al., 2011).
Drug Treatment
Cells were treated for 24 hours with DMSO or 50 nM trichostatin A (TSA) (Sigma). Cells 
were treated every 24 hours for a total of 48 hours with DMSO or 10 nM Tubastatin A 
(Cayman Chemical). For the inhibition of protein synthesis, cells were treated with DMSO 
or 0.1 mg/ml cycloheximide (Fisher).
Cell Lysates, Immunoprecipitation, Western Blotting, and HDAC activity
Whole cell, cytoplasmic, and nuclear lysates, and acid histone extracts were isolated as 
previously described (Abell et al., 2009; Abell et al., 2011). Immunoprecipitation, 
Antibodies and Sources, and HDAC Activity are specified in Supplemental Experimental 
Procedures.
qRT-PCR
RNA isolation, cDNA preparation, qRT-PCR and primers are specified in Supplemental 
Experimental Procedures.
Immunofluorescence
Whole cell immunostaining was performed as previously described (Abell et al., 2009). For 
nuclear staining, cells were trypsinized for 4 minutes, pelleted at 6000 rpm, and suspended 
in homogenization buffer (10 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 0.1 mM EGTA). 
Cells were disrupted by passage five times through a 25-gauge needle and nuclei pelleted. 
Nuclei were fixed for 10 minutes in 3% paraformaldehyde, suspended in PBS, and dried 
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onto coverslips. Immunostaining, Antibodies, and Confocal Imaging are specified in 
Supplemental Experimental Procedures.
RNA-seq and ChIP-seq
ChIP was modified from Abell et al 2011. Immunoprecipitation, antibodies, sequencing, 
analysis, visualization, and gene list enrichment are specified in Supplemental Experimental 
Procedures.
Barrier Function Measured by Transwell Solute Flux Assay
Cells were cultured at confluence for three days on Corning 3413 0.4 μm transwell 
permeable supports. 70 kDa rhodamine B isothiocynate-Dextran dye (1 mg/ml) was added 
to the top of each transwell and incubated for 2.5 hours. Fluorescence in the lower chamber 
was measured using a Synergy H1MD plate reader (BioTek).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
MAP3K4 promotes HDAC6 ubiquitination and degradation to maintain the 
epithelial state
Trophoblast stem cell differentiation and EMT induce HDAC6 expression and 
activity
Nuclear HDAC6 promotes EMT by direct deacetylation of tight junction gene 
promoters
MAP3K4 inhibits HDAC6 to control tight junctions during EMT
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Figure 1. TSKI4 cells exhibit reduced protein acetylation due to increased expression of HDAC6
Ablation of MAP3K4 kinase activity reduces the acetylation of several proteins.
(A) Western blots of 40 μg of whole cell lysate from TSWT and TSKI4 cells treated with 
DMSO (−) or 50 nM pan-deacetylase inhibitor, TSA (+) are shown. Blots are representative 
of four experiments. Arrows denote proteins with altered acetylation. (Exp, exposure)
(B) Western blots of 40 μg untreated TSWT and TSKI4 whole cell lysates are representative 
of two independent experiments.
(C) HDAC6 transcript increases upon loss of MAP3K4 activity. qRT-PCR data are from 
TSWT and TSKI4 cells expressing a control shRNA (C) or TSKI4 cells expressing two 
independent HDAC6 shRNAs (sh1 and sh2). Data are expressed as a fold change relative to 
TSWT cells and are the mean ± SEM of between three and five independent experiments.
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(D) HDAC6 protein increases with loss of MAP3K4 activity. Western blots of 10 μg whole 
cell lysates are representative of four independent experiments.
(E) Total cytoplasmic HDAC activity increases with loss of MAP3K4 activity. HDAC 
activity data show the mean ± SEM of four experiments.
(F) Cytoplasmic HDAC6 activity is increased in HDAC6 immunoprecipitates (IP) from 
TSKI4 relative to TSWT cytoplasmic lysate. Data show the mean ± SEM of three independent 
experiments. Blots show IP efficiency of the HDAC6 antibody relative to IgG control and 
are representative of three experiments.
Student’s t-test, *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001.
See also Figure S1.
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Figure 2. HDAC6 represses epithelial features in TS cells
Knockdown of HDAC6 in TSKI4 cells partially restores the epithelial morphology
(A–D) Phase microscopy images of TSWT (A) and TSKI4 (B) cells expressing a control 
shRNA or TSKI4 cells expressing two independent HDAC6 shRNAs (sh1 and sh2) (C,D) are 
shown. Representative images from four independent experiments are shown. Black bar 
represents 200 μm.
(E) E-cadherin transcript levels are not HDAC6 dependent. qRT-PCR data show the mean ± 
SEM of three independent experiments.
(F) Western blots of whole cell lysates are representative of three independent experiments.
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(G) E-cadherin localization is partially restored upon HDAC6 knockdown in TSKI4 cells. 
Confocal fluorescence images of E-cadherin staining are representative of three independent 
experiments. White bar represents 10 μm. Arrowheads indicate punctate intracellular 
localization of E-cadherin. Arrows indicate inset area.
(H) Krt8 and Krt18 transcript levels measured by qRT-PCR are dependent on HDAC6 
expression.
(I,J) Selective regulation of EMT inducing transcription factor expression by HDAC6 as 
measured by qRT-PCR.
(E,H–J) Data are expressed as a fold-change relative to TSWT cells. Data are the mean ± 
SEM of between three and four independent experiments.
(K) Invasion through growth factor reduced Matrigel by undifferentiated cells is shown. 
Data show the mean ± range of two independent experiments performed in triplicate. 
Student’s t-test, **p-value < 0.01; ***p-value < 0.001; ****p-value < 0.0001
See also Figure S2.
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Figure 3. MAP3K4 regulates HDAC6 expression and activity during normal TS cell 
differentiation and EMT through direct protein-protein interaction
(A–C) HDAC6 expression and activity are increased upon differentiation of TS cells. Cells 
were either undifferentiated (0) or differentiated for four days (4) in medium lacking FGF4, 
heparin, and MEF-CM.
(A) qRT-PCR data show the mean ± SEM of three independent experiments.
(B) Western blots of whole cell lysates are representative of three independent experiments.
(C) Cytoplasmic HDAC activity is expressed as the mean ± SEM of four independent 
experiments.
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(D) Co-expression of HA-MAP3K4 and FL-HDAC6 reduces cytoplasmic FL-HDAC6 
activity. FL-HDAC6 was immunoprecipitated from transfected 293 cells and HDAC6 
activity and expression were measured. Activity data are the mean ± range and blots are 
representative of two independent experiments.
(E) FL-HDAC6 was co-expressed with either wild-type or kinase-inactive HA-MAP3K4. 
FL-HDAC6 was immunoprecipitated and activity measured as described in (D). Activity 
data show the mean ± SEM of three independent experiments, relative to empty vector. Blots 
are representative of three independent experiments.
(F–H) The kinase domain of MAP3K4 binds HDAC6 independent of MAP3K4 kinase 
activity. 293 cells were transfected with the indicated constructs and blots were probed with 
the indicated antibodies.
(I,J) Endogenous MAP3K4 and HDAC6 co-immunoprecipitate in murine TS cells (I) and 
human 293 cells (J).
(F–J) Blots are representative of three independent experiments. (FL, Flag; KD, Kinase 
Domain; KI, Kinase Inactive; WT, wild-type; C, control; sh2, HDAC6 knockdown 
shRNA2).
Student’s t-test, *p-value < 0.05;***p-value < 0.001.
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Figure 4. MAP3K4 promotes the ubiquitination and degradation of HDAC6
(A–C) 293 cells were transfected with the indicated constructs. Western blots were probed 
with the indicated antibodies. (FL, Flag; KI, Kinase Inactive; WT, wild-type)
(A) Co-expression of wild-type HA-MAP3K4 and FL-HDAC6 increases the ubiquitination 
of HDAC6 but not MAP3K4. Samples were immunoprecipitated with the indicated antibody 
and probed for Myc-ubiquitin. Blots shown are representative of two independent 
experiments.
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(B) Kinase inactive MAP3K4 does not promote ubiquitination of HDAC6. Samples were 
immunoprecipitated using anti-FL antibody and probed for Myc-ubiquitin. Data shown are 
representative of four independent experiments.
(C) Ubiquitination of wild-type and kinase inactive MAP3K4 is not influenced by HDAC6. 
Samples were immunoprecipitated with anti-HA antibody and probed for Myc-ubiquitin. 
Blots shown are representative of three independent experiments.
(D) The degradation rate of endogenous HDAC6 is reduced in the absence of MAP3K4 
kinase activity. TSWT or TSKI4 cells were treated for the indicated number of hours with 
cycloheximide (CHX), an inhibitor of translation. Representative blots from three 
independent experiments are shown. Fold change relative to wild-type 0 hours was 
calculated by normalizing HDAC6 densitometry to total ERK.
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Figure 5. TSKI4 cells have increased nuclear HDAC6 localization and function
(A) Nuclear HDAC6 protein levels are elevated in TSKI4 cells. Western blots of nuclear 
lysates are from TSWT or TSKI4 cells expressing a control shRNA (C) or TSKI4 cells 
expressing HDAC6 shRNA 2 (sh2).
(B) Immunofluorescence microscopy images of isolated nuclei show increased nuclear 
HDAC6 (green) in TSKI4 cells relative to TSWT cells. Nuclei were stained with DAPI (blue) 
and LaminA/C (red). Arrowheads indicate nuclear HDAC6. White bar represents 50 μm.
(A,B) Images shown are representative of three independent experiments.
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(C) Increased total nuclear HDAC activity in TSKI4 cells expressed as the mean ± range of 
two independent experiments.
(D) Histone acetylation is restored by knockdown of HDAC6 in TSKI4 cells. Western blots 
are representative of three independent experiments.
(E–F) Differentiation and EMT induce nuclear HDAC6 localization and activity.
(E) Western blots of nuclear lysates from undifferentiated TSWT or TSKI4 cells (0) or cells 
differentiated four days (4). Blots are representative of two independent experiments.
(F) Nuclear HDAC activity assays were performed using nuclear lysates from 
undifferentiated cells or cells differentiated as in (E). Data are the mean ± range of two 
independent experiments.
(G–H) Western blots from cells undifferentiated (0) or differentiated for four days (4) as in 
(E). Blots are representative of three independent experiments.
(G) Histone acetylation is reduced with differentiation and EMT in TS cells.
(H) HDAC6 shRNA knockdown prevents differentiation-induced deacetylation of H2A/
H2B.
Student’s t-test, *p-value < 0.05.
See also Figure S3.
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Figure 6. HDAC6 directly binds and deacetylates the promoters of genes encoding tight junction 
proteins critical for maintaining the epithelial phenotype
(A) Bioinformatic analysis of anti-H2BK5Ac ChIP-seq data from TSWT or TSKI4 cells 
expressing a control shRNA or TSKI4 cells expressing HDAC6 sh2. 1817 genes showed 
MAP3K4/HDAC6 dependent changes in enrichment of H2BK5Ac at their promoters.
(B) ChIP-seq read density plots showing H2BK5Ac at the TSS ± 10 kb of 1817 MAP3K4/
HDAC6 dependent genes. Data are expressed as the intensity of the normalized read count 
of the IP divided by the normalized read count of the TSWT cell input.
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(C) ChIP-seq and RNA-seq data identify 514 candidate genes showing MAP3K4/HDAC6 
dependent changes in both H2BK5Ac and gene expression.
(D) Relative gene expression heat-map of 514 MAP3K4/HDAC6/H2BK5Ac dependent 
genes from RNA-seq data. Data columns show TSKI4 cell gene expression relative to TSWT 
cells and TSKI4 HDAC6sh2 cell gene expression relative to TSKI4 cells.
(E) ToppFun analysis of 514 MAP3K4/HDAC6/H2BK5Ac dependent genes. White numbers 
indicate the number of genes in each category.
(F) H2BK5Ac ChIP-seq read density plots at the Cldn6 TSS ± 2.5 kb. Data are expressed as 
in (B).
(G) Restored expression of Cldn6 upon knockdown of HDAC6 in TSKI4 cells. qRT-PCR 
data show fold changes relative to TSWT cells and are expressed as the mean ± SEM of three 
independent experiments.
(H) Knockdown of HDAC6 in TSKI4 cells to below wild-type levels restores Cldn6 protein.
(I) Confocal immunofluorescence microscopy showing restoration of tight-junction proteins 
Cldn6 (green) and ZO-1 (red) expression and localization in TSKI4 HDAC6sh2 cells. White 
bar represents 50 μm. Nuclei were stained with DAPI (blue). (H,I) Images shown are 
representative of four independent experiments.
(J) Reduced tight-junction barrier formation in TSKI4 cells is restored by HDAC6 
knockdown. Diffusion of fluorescent dye across a confluent monolayer of cells is shown as a 
fold-change relative to TSWT cells.
(K) Acetylation of H2BK5 on the Cldn6 promoter is restored upon knockdown of HDAC6 
in TSKI4 cells as measured by H2BK5Ac ChIP-PCR. Data shown are the mean ± SEM of 
between three and seven independent experiments.
(L) Enrichment of HDAC6 on the Cldn6 promoter in TSKI4 cells as measured by HDAC6 
ChIP-PCR. Data shown are the mean ± SEM of between three and five independent 
experiments.
Student’s t-test, *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001; ****p-value < 
0.0001.
See also Figure S4, Figure S5 and Table S1.
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Figure 7. HDAC6 directly deacetylates the promoters of genes important for EMT
(A–C) Expression of genes predicted to maintain the epithelial phenotype is restored by 
knockdown of HDAC6 in TSKI4 cells. qRT-PCR data expressed as a fold change relative to 
TSWT cells are the mean ± SEM of three independent experiments.
(D–F) Expression of the indicated genes was measured by qRT-PCR. The indicated cell lines 
were treated for 48 hours with vehicle DMSO (0) or 10 nM Tubastatin A (48). Data show 
the mean ± SEM of between two (F) and three (D,E) independent experiments.
(G) Transcripts were measured by qRT-PCR in TSWT cells infected with a control vector or 
shRNAs for the indicated genes. Data show the mean ± SEM of three independent 
experiments.
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(H–K) Shown are phase microscopy images of control infected TSWT cells (H) or TSWT 
cells expressing shRNAs for Ahnak (I), Pik3r3 (J), or Suox (K). Representative images from 
four independent experiments are shown. Black bar represents 200 μm.
(L–M) qRT-PCR data showing decreased epithelial markers (L) and increased endothelial 
and mesenchymal markers (M) for TSWT cells expressing the indicated shRNAs. Data 
shown are relative to control TSWT cells and are the mean ± SEM of three independent 
experiments.
(N–O) ChIP-PCR shows reduced H2BK5 acetylation (N) and enrichment of HDAC6 (O) on 
the promoters of specific genes in TSKI4 cells. Data shown are the mean ± SEM of three 
independent experiments.
Student’s t-test, *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001; ****p-value < 
0.0001.
See also Figure S6.
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